These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 658610)

  • 1. The effect of hyperglucagonemia on blood glucose concentrations and on insulin requirements in insulin-requiring diabetes mellitus.
    Clarke WL; Santiago JV; Kipnis DM
    Diabetes; 1978 Jun; 27(6):649-52. PubMed ID: 658610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyperglucagonemia and blood glucose regulation in normal, obese and diabetic subjects.
    Sherwin RS; Fisher M; Hendler R; Felig P
    N Engl J Med; 1976 Feb; 294(9):455-61. PubMed ID: 1246330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of three days of blood glucose normalization by means of an "artificial endocrine pancreas" on the concentrations of growth hormone, glucagon, and cortisol in juvenile diabetics.
    Schock A; Schultz M; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):93-6. PubMed ID: 395097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal alpha cell function in diabetics response to insulin.
    Unger RH; Madison LL; Muller WA
    Diabetes; 1972 May; 21(5):301-7. PubMed ID: 24683634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of insulin-glucose infusions on plasma glucagon levels in fasting diabetics and nondiabetics.
    Raskin P; Fujita Y; Unger RH
    J Clin Invest; 1975 Nov; 56(5):1132-8. PubMed ID: 1184740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of insulin infusion kinetics of an artificial beta cell on blood glucose control in insulin-dependent diabetics.
    Kerner W; Beischer W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):71-80. PubMed ID: 395094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperglucagonemia and its suppression. Importance in the metabolic control of diabetes.
    Raskin P; Unger RH
    N Engl J Med; 1978 Aug; 299(9):433-6. PubMed ID: 683275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An 'artificial beta cell' for control of diabetes mellitus: effect on plasma glucagon levels.
    Horwitz DL; Gonen B; Jaspan JB; Langer BG; Rodman D; Zeidler A
    Clin Endocrinol (Oxf); 1979 Dec; 11(6):639-44. PubMed ID: 394885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of hyperglucagonaemia on blood glucose concentrations and on insulin requirements during fasting in insulin dependent diabetes mellitus.
    Clarke WL; Melton TW; Bright GM
    Acta Endocrinol (Copenh); 1983 Apr; 102(4):557-60. PubMed ID: 6342325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppressibility of glucagon secretion by glucose in juvenile diabetes.
    Sperling MA; Aleck K; Voina S
    J Pediatr; 1977 Apr; 90(4):543-7. PubMed ID: 839365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Artificial pancreas: clinical and therapeutic value in 11 patients (author's transl)].
    Buysschaert M; Lambotte L; Lambert AE
    Nouv Presse Med; 1979 Jul 14-28; 8(32):2597-601. PubMed ID: 386266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D-Trp8-D-Cys14-somatostatin--demonstration of its differential suppressive activity in juvenile diabetics.
    Neuhaus C; Kerner W; Maier V; Pfeiffer EF
    Horm Metab Res Suppl; 1979; (8):115-8. PubMed ID: 395066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of daily insulin requirements in diabetics with an artificial endocrine pancreas.
    Lambert AE; Buysschaert M; Lambotte L
    Horm Metab Res Suppl; 1979; (8):120-7. PubMed ID: 395067
    [No Abstract]   [Full Text] [Related]  

  • 15. Effects of insulin on the response of immunoreactive glucagon to an intravenous glucose load in human diabetes.
    Yamamoto T; Raskin P; Aydin I; Unger R
    Metabolism; 1979 May; 28(5):568-74. PubMed ID: 449698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normalization of glycemia in diabetics during meals with insulin and glucagon delivery by the artificial pancreas.
    Marliss EB; Murray FT; Stokes EF; Zinman B; Nakhooda AF; Denoga A; Leibel BS; Albisser AM
    Diabetes; 1977 Jul; 26(7):663-72. PubMed ID: 873073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the suppressive effects of elevated plasma glucose and free fatty acid levels on glucagon secretion in normal and insulin-dependent diabetic subjects. Evidence for selective alpha-cell insensitivity to glucose in diabetes mellitus.
    Gerich JE; Langlois M; Noacco C; Lorenzi M; Karam JH; Korsham PH
    J Clin Invest; 1976 Aug; 58(2):320-5. PubMed ID: 783198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Normalization of the paradoxic secretion of glucagon in diabetics who were controlled by the artificial beta cell.
    Shichiri M; Kawamori R; Abe H
    Diabetes; 1979 Apr; 28(4):272-5. PubMed ID: 374171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The endocrine pancreas. From the isolated islet to the "artificial pancreas" (author's transl)].
    Schatz H; Pfeiffer EF
    MMW Munch Med Wochenschr; 1976 Apr; 118(16):485-92. PubMed ID: 818514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insulin, glucagon, and amino acids during glycemic control by the artificial pancreas in diabetic man.
    Hanna AK; Zinman B; Nakhooda AF; Minuk HL; Stokes EF; Albisser AM; Leibel BS; Marliss EB
    Metabolism; 1980 Apr; 29(4):321-32. PubMed ID: 6990172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.